# Trading Cycle Report - 2026-05-29

**Environment**: staging
**Cycle triggered**: manual via `POST http://agents-service:8000/api/trigger-cycle` at 06:42:24 UTC
**Total cycle duration**: 1m 50s (06:42:24 → 06:44:14)
**Overall result**: 4/4 completed, 4 trades executed, 0 failed
**Deployment context**: Cycle run immediately after the at-deploy staging push of all components. Backend tests now pass cleanly after the `SharedPostgresContainer` test-fixture refactor — the prior XML-reporter crash from per-class Testcontainers postgres pools is gone, build green.

---

## Cycle Summary (06:42 UTC)

| Agent  | Style              | Decision | Symbol | Qty | Price    | Total       | Candidates                  |
|--------|--------------------|----------|--------|-----|----------|-------------|-----------------------------|
| George | Contrarian Macro   | BUY      | WFC    | 91  | $76.65   | $6,975.15   | FCX, MOS, WFC               |
| Cathie | Growth Innovation  | BUY      | PATH   | 670 | $11.58   | $7,758.60   | MBLY, PATH, TER, NTLA, COIN |
| Ray    | Risk Parity        | SELL     | T      | 248 | $24.88   | $6,170.24   | KO, MCD, KMB                |
| Warren | Value Investor     | SELL     | IBM    | 25  | $264.22  | $6,605.50   | ORCL, KO, PEP               |

---

## Portfolio Snapshots (Latest)

| Agent  | Cash         | Holdings Value | Total Value   | Total P&L     | Return %   |
|--------|--------------|----------------|---------------|---------------|------------|
| Warren | $43,046.15   | $67,682.11     | $110,728.26   | +$10,728.26   | +10.73%    |
| George | $28,160.86   | $76,444.66     | $104,605.52   | +$4,605.52    | +4.61%     |
| Ray    | $42,323.30   | $55,349.97     | $97,673.27    | −$2,326.73    | −2.33%     |
| Cathie | $23,315.67   | $104,546.86    | $127,862.53   | +$27,862.53   | +27.86%    |
| **Combined** | **$136,845.98** | **$304,023.60** | **$440,869.58** | **+$40,869.58** | **+10.22%** |

### Current Holdings

**Warren (account_id=1)** — 9 positions: ADP, BRK.B, JNJ, MCD, MRK, MSFT, PG, UNP, V

**George (account_id=2)** — 10 positions: CCJ, FNV, GOLD, MP, RTX, SCCO, UEC, WFC, XOM, ZIM

**Ray (account_id=3)** — 9 positions: ADP, ATO, CVX, ITW, JNJ, MDT, PG, TRV, WM

**Cathie (account_id=4)** — 10 positions: AMD, ARM, ASML, GOOGL, ISRG, MSFT, NVDA, PATH, SNOW, TSLA

---

## Detailed Run Data

### Run 513: George (Contrarian Macro) — BUY WFC

**Started**: 06:42:24 UTC | **Completed**: 06:43:47 UTC (~1m 23s) | **Status**: COMPLETED

#### Research Phase (53,750ms)
**Candidates**: FCX, MOS, WFC

**Tool Calls** (6):
1. `brave_web_search(query="copper demand electrification 2026 Freeport McMoRan outlook 2026 copper supply deficit", count=10)`
2. `brave_web_search(query="fertilizer supply 2026 Mosaic company outlook 2026 potash phosphate Mosaic earnings 2026 fertilizer geopolitics Russia sanctions food security 2026 MOS", count=10)`
3. `brave_web_search(query="Wells Fargo 2026 outlook deposit flows net interest margin 2026 contrarian bank stocks investors concerns Wells Fargo outlook 2026 Reuters analysis", count=10)`
4. `lookup_price_tool(symbol="FCX")`
5. `lookup_price_tool(symbol="MOS")`
6. `lookup_price_tool(symbol="WFC")`

**Research Notes**:
> Macro-driven, contrarian shortlist for one new high-conviction slot. 1) Freeport-McMoRan (FCX): structural copper deficits from electrification, AI/data-center buildout and recent mine disruptions create asymmetric upside for large, liquid copper exposure if supply shocks persist. 2) The Mosaic Company (MOS): fertilizer supply tightness and geopolitically-driven trade frictions create upside in potash/phosphate prices; Mosaic is priced for short-term margin stress but gains if prices and volumes normalize. 3) Wells Fargo (WFC): bank-sector sentiment remains muted; a resilient economy with higher-for-longer rates supports NII and capital returns—WFC is a contrarian financial play to diversify away from commodity-heavy holdings.
>
> Each idea is selected to complement existing positions (commodities/energy/gold/uranium) while adding targeted macro exposure: FCX = copper/energy transition, MOS = food security/commodity dislocation, WFC = rate-sensitive financial exposure and idiosyncratic downside already priced in.

**Web Sources**:
- [UBS raises copper outlook as mine disruptions deepen supply deficits — Reuters](https://www.reuters.com/business/finance/ubs-raises-copper-outlook-mine-disruptions-deepen-supply-deficits-2025-11-24/)
- [Substantial Shortfall in Copper Supply Widens as the Race for AI and Growing Defense Spending Add to Accelerating Demand — S&P Global](https://press.spglobal.com/2026-01-08-Substantial-Shortfall-in-Copper-Supply-Widens-as-the-Race-for-AI-and-Growing-Defense-Spending-Add-to-Accelerating-Demand,-New-S-P-Global-Study-Finds)
- [Freeport-McMoran Beat Q1 2026 Earnings. Why Is the Stock Still Under $61? — TIKR](https://www.tikr.com/blog/freeport-mcmoran-beat-q1-2026-earnings-why-is-the-stock-still-under-61)
- [Mosaic Issues Market Update And Preliminary Fourth Quarter 2025 Sales Results](https://investors.mosaicco.com/press-releases/news-details/2026/Mosaic-Issues-Market-Update-And-Preliminary-Fourth-Quarter-2025-Sales-Results/default.aspx)
- [Mosaic Co — Reuters](https://www.reuters.com/company/mosaic-co/)
- [Global Fertilizer Prices Set to Surge 21% as Trade Restrictions Bite — Wedbush Market Minute](https://investor.wedbush.com/wedbush/article/marketminute-2026-3-20-global-fertilizer-prices-set-to-surge-21-as-trade-restrictions-bite)
- [Wells Fargo misses expectations on interest income, revenue; shares fall — Reuters](https://www.reuters.com/business/finance/wells-fargo-profit-rises-interest-income-boost-2026-04-14/)
- [Wells Fargo Stock 2026 Outlook — Forbes](https://www.forbes.com/sites/greatspeculations/2025/12/17/wells-fargo-stock-2026-outlook/)
- [Wells Fargo Investment Institute: 2026 Poised for Markets Growth as Familiar Trends Create Potential Opportunities](https://newsroom.wf.com/news-releases/news-details/2025/Wells-Fargo-Investment-Institute-2026-Poised-for-Markets-Growth-as-Familiar-Trends-Create-Potential-Opportunities/default.aspx)

**Portfolio Context**: Balance $35,136.01, 9 positions (XOM, FNV, UEC, GOLD, RTX, MP, ZIM, SCCO, CCJ)

#### Decision Phase (21,821ms)
**Decision**: BUY WFC × 91 @ $76.65

**Reasoning**:
- **Rationale**: Diversify away from commodity concentration into a contrarian, rate-sensitive bank: Wells Fargo is priced for persistent pessimism while a higher-for-longer rate regime and resilient credit conditions should lift NII and capital returns, creating asymmetric upside vs. the commodity candidates.
- **Research**: Candidates considered: FCX ($65.87) — strong copper deficit thesis (S&P Global copper shortfall; Reuters coverage) supporting upside but increases base-metal concentration; MOS ($24.06) — fertilizer upside if prices normalize (Analyst notes: trailing P/E mid-teens, short-term margin stress per Mosaic update/Reuters/Wedbush) but cyclical and overlaps commodity exposure; WFC ($76.65) — bank-sector sentiment muted after recent misses (Reuters) yet benefits from higher net interest income and capital return optionality (Forbes/Wells Fargo Institute outlook). Chosen WFC for contrarian asymmetric payoff: market pricing reflects near-term weakness while macro (higher rates, resilient economy) should re-rate NII and dividends/share buybacks; trade validated by no prior WFC exposure and fits position/cash limits.
- **Portfolio**: Cash $35,136.01; positions 9/10 — current book is commodity/energy/gold/uranium heavy (XOM, FNV, UEC, GOLD, SCCO, CCJ, etc.). This buy uses one available slot, deploys $6,975.15 (91 shares × $76.65) — within the $7,027.20 single-position cap — and materially diversifies the portfolio into financials/rate exposure while preserving liquidity for future macro dislocations.
- **Historical**: WFC: no prior trades in the last 90 days (no position). FCX: prior accumulation and partial sell activity (multiple buys Apr–May 2026, pattern 'accumulating'); MOS: prior buy/sell (~Apr 2026) — mixed history. I avoided FCX and MOS because they would increase existing commodity concentration and I have recent trade activity/positioning in that sector.

**Decision Tool Calls** (3):
1. `get_symbol_trade_history(symbol="FCX")`
2. `get_symbol_trade_history(symbol="MOS")`
3. `get_symbol_trade_history(symbol="WFC")`

#### Execution
**Trade #412**: BUY 91 shares WFC @ $76.65 = $6,975.15 — account_id=2 (George)

---

### Run 514: Cathie (Growth Innovation) — BUY PATH

**Started**: 06:42:24 UTC | **Completed**: 06:43:58 UTC (~1m 34s) | **Status**: COMPLETED

#### Research Phase (67,067ms)
**Candidates**: MBLY, PATH, TER, NTLA, COIN

**Tool Calls** (11):
1. `brave_web_search(query="Mobileye UiPath Teradyne Intellia Block 2026 news revenue R&D investor presentation 2026", count=10)`
2. `brave_web_search(query="Intellia Therapeutics NTLA 2026 clinical trial revenue 2026 news AND Block SQ 2026 earnings bitcoin Cash App 2026 news", count=10)`
3. `brave_web_search(query="Intellia Therapeutics 2026 CRISPR clinical trials 2026 news NTLA revenue 2026 press release", count=10)`
4. `brave_web_search(query="Block SQ 2026 Q1 2026 earnings Cash App Bitcoin growth 2026 news Square Block 2026 investor relations", count=10)`
5. `lookup_price_tool(symbol="MBLY")`
6. `lookup_price_tool(symbol="PATH")`
7. `lookup_price_tool(symbol="TER")`
8. `lookup_price_tool(symbol="NTLA")`
9. `lookup_price_tool(symbol="SQ")`
10. `lookup_price_tool(symbol="COIN")`
11. `brave_web_search(query="Coinbase Q1 2026 earnings news COIN 2026 exchange crypto infrastructure 2026 investor relations press release", count=10)`

**Research Notes**:
> I selected five high-conviction, disruptive-innovation candidates that complement existing positions in AI chips and cloud (NVDA, MSFT, GOOGL) by adding exposure to autonomous driving sensors, enterprise AI automation, factory/robotics automation, CRISPR therapeutics, and crypto infrastructure. Mobileye (MBLY) is a leader in computer-vision ADAS and autonomous stacks with recent double-digit revenue growth and updated guidance. UiPath (PATH) offers enterprise AI/automation (RPA) with recurring ARR expansion and improved profitability metrics. Teradyne (TER) provides differentiated exposure to automation and semiconductor test equipment (including industrial robots via acquisitions), benefiting secular AI chip testing demand. Intellia (NTLA) is a CRISPR gene-editing leader with positive Phase-3 progress and an advancing commercial pathway. Coinbase (COIN) is the largest US crypto exchange/platform, strengthening its infrastructure and diversified revenue base post-2026 results.
>
> These names are selected to be high-conviction, non-duplicate exposures (I avoided adding more weight to NVDA, AMD, ASML, MSFT, GOOGL, TSLA, ARM, ISRG, SNOW). Each candidate shows product- or pipeline-led optionality, meaningful R&D/technical investment, and clear TAM expansion potential appropriate for a growth-innovation sleeve while keeping the portfolio balanced near capacity.

**Web Sources**:
- [Mobileye Releases First Quarter 2026 Results, Updates Full-Year Outlook, and Announces a $250 Million Share Repurchase Program](https://ir.mobileye.com/financial-information/quarterly-results)
- [Mobileye reports 27% revenue growth, raises 2026 guidance — Investing.com](https://www.investing.com/news/company-news/mobileye-reports-27-revenue-growth-raises-2026-guidance-93CH-4632029)
- [UiPath Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results](https://ir.uipath.com/news/detail/431/uipath-reports-fourth-quarter-and-full-year-fiscal-2026-financial-results)
- [Teradyne, Inc. Investor Relations](https://investors.teradyne.com/)
- [Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates](https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-first-quarter-2026-financial)
- [Coinbase Q1 Financial Results Show Resilient Financial Performance](https://investor.coinbase.com/news/news-details/2026/Coinbase-Q1-Financial-Results-Show-Resilient-Financial-Performance-Driven-by-New-All-Time-High-Crypto-Trading-Volume-Market-Share/default.aspx)

**Portfolio Context**: Balance $31,074.27, 9 positions (NVDA, ISRG, AMD, GOOGL, ASML, SNOW, TSLA, ARM, MSFT)

#### Decision Phase (19,502ms)
**Decision**: BUY PATH × 670 @ $11.58

**Reasoning**:
- **Rationale**: Buy PATH — capital-efficient leader in enterprise RPA/agentic AI with expanding ARR and improving margins, offering the highest conviction, lower-execution-risk way to add differentiated software automation exposure to our AI compute/cloud core.
- **Research**: Market Analyst candidates: MBLY ($10.41; Mobileye reported 27% revenue growth, raised 2026 guidance and announced $250M repurchase), PATH ($11.58; UiPath — enterprise RPA with recurring ARR expansion and cited mid-20s software multiple), TER ($382.65; Teradyne — semiconductor test and industrial robotics exposure benefiting AI chip test demand), NTLA ($13.68; Intellia — in-vivo CRISPR with Phase-3 progress but binary biotech risk), COIN ($182.25; Coinbase — largest US crypto exchange with infrastructure optionality but elevated forward P/E ~53.9 and regulatory/volume cyclicality). I choose PATH over MBLY/TER/NTLA/COIN because PATH delivers scalable, recurring software economics and faster optionality into enterprise agentic automation (mid-20s multiple cited by Analyst), is capital-efficient vs. hardware (TER/MBLY) and avoids biotech binary risk (NTLA) and crypto cyclicality/regulatory risk (COIN).
- **Portfolio**: Cash $31,074.27, positions 9/10; adding PATH uses one open slot and deploys $7,758.60 (670 × $11.58) — within the $7,768.57 max per-position limit — and complements existing NVDA/MSFT/GOOGL cloud+compute holdings by adding product-led enterprise automation exposure without materially increasing hardware concentration.
- **Historical**: Trade history shows mixed activity in PATH over the past 90 days (multiple buy/sell rounds: buys at $10.27–$10.89 and sells at $10.33–$10.83), indicating active rebalancing; no current net position — prior trades demonstrate operational familiarity but also timing churn, so I size to the max allowed to reestablish a conviction position while limiting concentration risk.

**Decision Tool Calls** (1):
1. `get_symbol_trade_history(symbol="PATH")`

#### Execution
**Trade #413**: BUY 670 shares PATH @ $11.58 = $7,758.60 — account_id=4 (Cathie)

---

### Run 515: Ray (Risk Parity) — SELL T

**Started**: 06:42:24 UTC | **Completed**: 06:43:40 UTC (~1m 16s) | **Status**: COMPLETED

#### Research Phase (46,793ms)
**Candidates**: KO, MCD, KMB

**Tool Calls** (5):
1. `brave_web_search(query="Coca-Cola McDonald's Kimberly-Clark dividend aristocrat beta yield defensive stocks low volatility dividend yield sources KO MCD KMB", count=10)`
2. `brave_web_search(query="McDonald's dividend yield beta MCD dividend aristocrat beta yield 2026 sources McDonald's investor relations yield beta", count=10)`
3. `lookup_price_tool(symbol="KO")`
4. `lookup_price_tool(symbol="MCD")`
5. `lookup_price_tool(symbol="KMB")`

**Research Notes**:
> I selected three low-beta, defensive dividend aristocrats — KO, MCD, and KMB — that fit a risk-parity, all-weather approach. Each is a high-quality, cash-generative business with long dividend records, low market volatility relative to growth names, and exposure to recession-resistant consumer demand (beverages/food/paper products). These names provide stable income, sector diversification from current holdings, and historically low correlations to cyclical industrials and energy.
>
> From a risk-parity perspective these candidates help stabilize portfolio volatility and deliver reliable cash flow across economic regimes (deflation/recession resilience via staples and consumer staples services; steady nominal returns in mild inflation via pricing power). Consider using them to rebalance an oversized position (e.g., reduce concentration in T) or to replace a single holding with similar risk but stronger payout/low-beta characteristics.

**Web Sources**:
- [The Coca-Cola Company (KO) Dividend Summary, Yield, History & Payouts — Seeking Alpha](https://seekingalpha.com/symbol/KO/dividends/scorecard)
- [The Coca-Cola Company (KO) Dividend History, Dates & Yield — StockAnalysis](https://stockanalysis.com/stocks/ko/dividend/)
- [2026 Dividend Aristocrats List — Sure Dividend](https://www.suredividend.com/dividend-aristocrats-list/)
- [McDonald's (MCD) Dividend History, Dates & Yield — StockAnalysis](https://stockanalysis.com/stocks/mcd/dividend/)
- [Dividend Aristocrats In Focus: McDonald's Corporation — Sure Dividend](https://www.suredividend.com/dividend-aristocrats-mcd/)
- [MCD - McDonald's Corp Dividends — Morningstar](https://www.morningstar.com/stocks/xnys/mcd/dividends)
- [Kimberly-Clark - 39 Year Dividend History — MacroTrends](https://www.macrotrends.net/stocks/charts/KMB/kimberly-clark/dividend-yield-history)
- [Kimberly-Clark (KMB) Dividend History, Dates & Yield — StockAnalysis](https://stockanalysis.com/stocks/kmb/dividend/)
- [KMB: Dividend Date & History for KIMBERLY-CLARK CORPORATION — Dividend.com](https://www.dividend.com/stocks/consumer-staples/consumer-products/household-products/kmb-kimberly-clark/)

**Portfolio Context**: Balance $36,153.06, 10 positions (WM, ITW, PG, CVX, ATO, TRV, T, MDT, JNJ, ADP)

#### Decision Phase (21,482ms)
**Decision**: SELL T × 248 @ $24.88

**Reasoning**:
- **Rationale**: Reduce an outsized telecom concentration and create the open slot/cash needed to add a low-beta dividend aristocrat (KO/MCD/KMB) that better fits the portfolio's risk-parity diversification goals.
- **Research**: Market Analyst candidates: KO (price $80.41; P/E mid-20s; yield ≈2.7–3%), MCD (price $277.97; P/E mid-20s; yield ≈2.1–2.5%), KMB (price $100.14; trailing P/E low-teens; yield ≈4%+). All are low-beta, defensive dividend aristocrats that add staples income and lower correlation vs existing cyclicals (ITW, CVX). Because the book is at the 10/10 limit, I must sell before adding—T is a clear over-weight that reducing will (a) lower concentration risk, (b) create the slot to add a candidate sized to the $5,422.96 cap, and (c) improve risk-adjusted diversification by allowing entry into KO/MCD/KMB (KMB offers higher yield/valuation cushion; KO/MCD provide stable franchises and low beta).
- **Portfolio**: Cash $36,153.06; positions 10/10 (WM, ITW, PG, CVX, ATO, TRV, T, MDT, JNJ, ADP). Selling T (full 248-share position) frees a position slot and material cash to add one of the Analyst's low-beta dividend aristocrats sized to the $5,422.96 per-position cap without exceeding budget or position limits.
- **Historical**: get_symbol_trade_history shows a mixed trading pattern for T: current holding 248 shares (average cost $25.44); recent buy 248 @ $24.74 (2026-05-14) and prior sells in late April — indicates active sizing and available liquidity to exit without forcing a replacement in the same cycle.

**Decision Tool Calls** (1):
1. `get_symbol_trade_history(symbol="T")`

#### Execution
**Trade #411**: SELL 248 shares T @ $24.88 = $6,170.24 — account_id=3 (Ray)

---

### Run 516: Warren (Value Investor) — SELL IBM

**Started**: 06:42:24 UTC | **Completed**: 06:44:14 UTC (~1m 50s) | **Status**: COMPLETED

#### Research Phase (74,383ms)
**Candidates**: ORCL, KO, PEP

**Tool Calls** (10):
1. `brave_web_search(query="Oracle ORCL valuation free cash flow ROE 2026 undervalued", count=5)`
2. `brave_web_search(query="ORCL Yahoo Finance profile P/E ROE debt-to-equity free cash flow 2026", count=5)`
3. `brave_web_search(query="Coca-Cola KO P/E ROE debt-to-equity free cash flow 2026 undervalued article", count=5)`
4. `brave_web_search(query="Chevron CVX P/E ROE free cash flow debt-to-equity 2026 undervalued analysis", count=5)`
5. `brave_web_search(query="Exxon Mobil XOM P/E ROE free cash flow 2026 undervalued analysis", count=5)`
6. `brave_web_search(query="Coca-Cola KO return on equity ROE 2026 5-year ROE", count=10)`
7. `brave_web_search(query="PepsiCo PEP ROE 2026 return on equity 5-year ROE P/E valuation 2026 undervalued", count=5)`
8. `lookup_price_tool(symbol="ORCL")`
9. `lookup_price_tool(symbol="KO")`
10. `lookup_price_tool(symbol="PEP")`

**Research Notes**:
> I screened for durable-moat, high-ROE businesses trading at modest valuations relative to peers and with strong free-cash-flow. Oracle (ORCL) is an enterprise-software cash-generator with very high ROE driven by buybacks and recurring cloud/DB revenue; valuation appears reasonable versus historical norms. Coca-Cola (KO) is a classic brand moat with multi-decade earnings stability, very high ROE and steady FCF/dividends. PepsiCo (PEP) combines beverage/snacks diversification, strong margins/ROE and consistent cash generation.
>
> Each candidate complements the current portfolio exposure while offering clearer value/financial-metric advantages vs possible replacements (notably ORCL vs IBM; KO/PEP vs PG). Key risks: ORCL — accounting/equity-base distortions and software competition; KO/PEP — slower growth/currency and commodity cost pressure. I selected these three to propose as value-oriented replacements/additions consistent with a long-term, patient value approach.

**Web Sources**:
- [Oracle Corporation (ORCL) Stock Price, News, Quote & History — Yahoo Finance](https://finance.yahoo.com/quote/ORCL/)
- [Oracle (ORCL) Statistics & Valuation — StockAnalysis](https://stockanalysis.com/stocks/orcl/statistics/)
- [ORCL Intrinsic Valuation and Fundamental Analysis — Alpha Spread](https://www.alphaspread.com/security/nyse/orcl/summary)
- [The Coca-Cola Company (KO) Valuation Measures & Financial Statistics — Yahoo Finance](https://finance.yahoo.com/quote/KO/key-statistics/)
- [Coca-Cola (KO) Return on Equity (ROE) — Current & Historical Data — FinanceCharts](https://www.financecharts.com/stocks/KO/growth/roe)
- [KO Intrinsic Valuation and Fundamental Analysis — Alpha Spread](https://www.alphaspread.com/security/nyse/ko/summary)
- [PEPSICO ROE %: 51.06% — Near Median — GuruFocus](https://www.gurufocus.com/term/roe/PEP)
- [PepsiCo (PEP) Return on Equity (ROE) — Current & Historical Data — FinanceCharts](https://www.financecharts.com/stocks/PEP/growth/roe)
- [PepsiCo ROE - Return on Equity 2012-2026 — MacroTrends](https://www.macrotrends.net/stocks/charts/PEP/pepsico/roe)

**Portfolio Context**: Balance $36,440.65, 10 positions (IBM, BRK.B, PG, MSFT, JNJ, MCD, ADP, MRK, UNP, V)

#### Decision Phase (30,393ms)
**Decision**: SELL IBM × 25 @ $264.22

**Reasoning**:
- **Rationale**: Sell full IBM stake to free a position slot and capital — IBM carries execution/turnaround risk vs. the Market Analyst's preferred enterprise candidate (ORCL) which shows stronger ROE/FCF at a more attractive valuation for our value mandate.
- **Research**: Market Analyst candidates: ORCL ($203.70) — enterprise software with very high ROE, strong FCF and buybacks; analyst notes mid-20s P/E and favorable DCF/valuation (sources: Yahoo Finance ORCL page; StockAnalysis ORCL; AlphaSpread ORCL). KO ($80.41) — classic wide moat, trailing P/E ≈ mid-20s and ~2.7–2.8% dividend (source: Yahoo Finance KO; AlphaSpread KO); PEP ($146.29) — beverage/snacks diversification, trailing P/E mid-20s and steady FCF/ROE (sources: Yahoo Finance PEP; GuruFocus/MacroTrends). I sell IBM rather than trimming staples (PG/MCD) because ORCL better fits our value criteria (higher ROE, recurring cloud/DB revenue, stronger FCF and shareholder returns) and IBM's transformation/execution risk plus recent churn reduce its conviction as a long-term holding (Market Analyst notes and account research as cited).
- **Portfolio**: Cash $36,440.65; positions 10/10 — selling 25 IBM shares reduces holdings to 9/10 and increases cash to fund a future high-conviction replacement (target: ORCL) while keeping per-position cap ($5,466.10) and diversification limits intact.
- **Historical**: Account trade history shows mixed IBM activity (recent buys/sells on 2026-05-05/06) and a current 25-share holding, indicating limited conviction and churn; selling now closes this lower-conviction exposure and avoids repeated short-term trading in a turnaround name (see get_symbol_trade_history for IBM).

**Decision Tool Calls** (2):
1. `get_symbol_trade_history(symbol="ORCL")`
2. `get_symbol_trade_history(symbol="IBM")`

#### Execution
**Trade #414**: SELL 25 shares IBM @ $264.22 = $6,605.50 — account_id=1 (Warren)

---

## Aggregate Statistics

| Metric | Value |
|--------|-------|
| Total Runs | 4 |
| Successful | 4 (100%) |
| Failed | 0 |
| Total Trades | 4 (2 BUY, 2 SELL) |
| HOLD Decisions | 0 |
| Capital Deployed (BUY) | $14,733.75 |
| Capital Returned (SELL) | $12,775.74 |
| Net Cash Change | −$1,958.01 |
| Avg Research Latency | 60,498 ms |
| Avg Decision Latency | 23,300 ms |
| Total Research Tool Calls | 32 (8 avg/run) |
| Total Decision Tool Calls | 7 |
| Combined Portfolio Value | $440,869.58 |
| Combined P&L | +$40,869.58 |
| Combined Return | +10.22% (on $400K seed) |

---

## Comparison with Previous Report

**Previous**: TRADING_CYCLE_REPORT_20260526_3.md (cycle at 20:37 UTC, 2026-05-26 — first post-Phase-C cycle)
**Current**: TRADING_CYCLE_REPORT_20260529.md (cycle at 06:42 UTC, 2026-05-29 — first post-SharedPostgresContainer-refactor cycle)

| Metric | Previous (2026-05-26) | Current (2026-05-29) | Status |
|--------|------------------------|-----------------------|--------|
| Completion Rate | 4/4 (100%) | 4/4 (100%) | ✅ OK |
| Trades Executed | 4 (2 BUY, 2 SELL) | 4 (2 BUY, 2 SELL) | ✅ OK |
| HOLD Decisions | 0 | 0 | ✅ OK |
| Failed Runs | 0 | 0 | ✅ OK |
| Reasoning Fields Complete | 4/4 | 4/4 | ✅ OK |
| Missing Phases | 0 | 0 | ✅ OK |
| Cycle Duration | 1m 47s | 1m 50s | ✅ OK (within LLM variance) |
| Avg Research Latency | 52,598 ms | 60,498 ms | ⚠️ +15% (within normal LLM/MCP variance) |
| Avg Decision Latency | 36,334 ms | 23,300 ms | ✅ −36% faster |
| Avg Research Tool Calls/run | 7.0 | 8.0 | ✅ OK (slightly more) |
| Combined Portfolio Value | $438,094.10 | $440,869.58 | +$2,775.48 (+0.63%) |

### Per-agent P&L delta (cycle 2026-05-26 → 2026-05-29)

| Agent | Previous Total | Current Total | Δ Total | Δ % |
|---|---:|---:|---:|---:|
| Warren | $110,533.13 | $110,728.26 | +$195.13 | +0.18% |
| George | $105,180.09 | $104,605.52 | −$574.57 | −0.55% |
| Ray | $98,345.99 | $97,673.27 | −$672.72 | −0.68% |
| Cathie | $124,034.89 | $127,862.53 | +$3,827.64 | +3.08% |
| **Combined** | **$438,094.10** | **$440,869.58** | **+$2,775.48** | **+0.63%** |

### Regressions Found

**None.** All system paths exercised end-to-end without error:

- **All 4 runs completed** with full research, decision, and execution phases persisted.
- **4 trades persisted** into `trading.account_transactions` (IDs 411–414) with correct symbol, quantity, price, total_amount, and account linkage.
- **All decision reasoning fields populated** (`rationale`, `researchContext`, `portfolioContext`, `historicalContext`) — no nulls.
- **All `get_symbol_trade_history` MemoryService tool calls returned populated trade history correctly** — visible in each run's historical reasoning text, citing specific dates and prices from prior trades.
- **No XML reporter crash on the build** that produced the deployed backend image — the `SharedPostgresContainer` JVM-wide singleton refactor (5 integration test classes consolidated onto one shared Testcontainer instance) eliminates the prior Hikari-pool teardown contention that caused the `TradingRunServiceTest$CreateRunTests.xml` 0-byte file.

### Notable behavioral observations (model, not system)

1. **Cathie reversed PATH direction.** Decision history shows PATH bought at $10.27–$10.89 and sold at $10.33–$10.83 over the last 90 days — multiple round-trips. This cycle's BUY at $11.58 re-enters at a higher price than recent sells. *Same-day-trade-pattern observation, not a system issue — Phase C MemoryService correctly served Cathie the full PATH history and the LLM still chose to re-enter.*
2. **Warren executed a plan from the previous cycle.** Previous (2026-05-26 cycle 3) SELL'd AAPL with a stated plan to add ORCL on a future cycle. This cycle's SELL IBM frees the slot with the same ORCL target in mind. **Multi-cycle consistency preserved.**
3. **Ray repeated the T-thinning pattern.** Account history shows recent buy 248 T @ $24.74 (2026-05-14). This cycle SELL'd 248 T @ $24.88 — small gain, but another short-cycle churn in the same name. Similar to Cathie's PATH pattern, this is LLM behavior rather than a system regression.
4. **George reallocated from commodities into financials.** First WFC position (no prior 90-day trades) — adds rate-sensitive exposure to a previously commodity-heavy book (XOM, FNV, UEC, GOLD, MP, SCCO, CCJ, RTX, ZIM).

### System-health verdict

✅ **Staging is healthy end-to-end after the SharedPostgresContainer refactor and at-deploy push.**

- All 4 services rolled cleanly; backend/agents/frontend log scans returned no critical errors.
- Backend Hikari connections to postgres-0 are stable.
- Agent pipeline (MA → DM → execution → DB persist → WebSocket broadcast) verified through one full manual cycle.
- Phase C contracts (MemoryService constructor injection, repository date filter pushdown, empty factories) continue working — visible in every agent's historical reasoning.

---

## Open follow-ups

1. **Research latency drift (+15%)** — average research-phase latency went from 52.6s to 60.5s. Within normal Brave/Fetch MCP and OpenAI variance, but worth keeping an eye on if it climbs further. Decision-phase latency dropped 36% on the same cycle, so the round-trip is net-faster.
2. **Cathie + Ray same-name reversal pattern** — both agents traded in/out of the same symbol within the last 14 days (PATH, T). Phase C's memory is *informing* the LLM correctly (each decision cites the prior trades) but the LLM still chooses to reverse. A future intervention (e.g., a same-symbol cool-down constraint in the decision prompt or a guardrail check) could reduce this churn.
3. **Production parity** — prod was deployed and verified in the prior session (runs 1161–1164 with 3 trades + 1 HOLD persisted). Staging now ahead of prod by the SharedPostgresContainer test refactor; that's test-side only, no behavior delta in shipped image vs. prod.
